Page 31 of today's AFR puts a positive spin on Clover. Says, strong 2H sales should put Clover on track for good 2012 growth. Analysts expect growth margins to lift over next year as company ramps up new product lines. Asia Pacific markets are big consumers of infant formula & foods will drive growth allowing management to focus on organic sales growth (with $25m of new project sales due). Estimated sales FY11 to be about $33m. Microequities' target price 39c.
mjpw
afr
Add CLV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $84.33M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13622 | 50.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.0¢ | 54627 | 1 |
View Market Depth
| Last trade - 07.00am 30/05/2024 (20 minute delay) ? |
| CLV (ASX) Chart |
Day chart unavailable